{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:18:19Z","timestamp":1783937899309,"version":"3.55.0"},"reference-count":19,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T00:00:00Z","timestamp":1152576000000},"content-version":"vor","delay-in-days":4849,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[1993,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report on the use of leuprolide to prevent heavy menstrual bleeding that often occurs before platelet engraftment in premenopausal women undergoing bone marrow transplantation (BMT). Leuprolide, a synthetic analog of gonadotropin\u2010releasing hormone (Gn\u2010RH\u2010a), was given to 34 patients by intravenous bolus injection, 1 mg daily, until platelet recovery. The median duration of therapy was 50 days (range 16\u2013170). When necessary, patients self\u2010administered the drug after discharge from the hospital. No adverse effects could be related directly to the use of leuprolide. Leuprolide effectively prevented menstruation in 25 patients (73%), failed in seven (21%), and two patients were not evaluable. The success of leuprolide therapy was related to the time of onset of treatment, as anticipated from the gradual effect of Gn\u2010RH\u2010a on the menstrual cycle. The failure rate was only 6% (one of 16 patients) when leuprolide was started at least 2 weeks prior to the development of thrombocytopenia, compared to a failure rate of 33% (six of 18 patients) when leuprolide was started at a later time. We conclude that leuprolide as a single agent is a safe and effective method to prevent menstrual bleeding during BMT. Additional studies are needed to determine the best timing for the onset of therapy and the relative benefit of leuprolide compared to other prophylactic approaches in patients with lengthy thrombocytopenia. \u00a9 1993 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.2830420404","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T13:18:36Z","timestamp":1172063916000},"page":"350-353","source":"Crossref","is-referenced-by-count":30,"title":["Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation"],"prefix":"10.1002","volume":"42","author":[{"given":"Richard","family":"Ghalie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlene","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Radwanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Fitzsimmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Richman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Kaizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,7,11]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"2648","article-title":"Alterations of the menstrual cycle","volume":"4","author":"Cumming DC","year":"1987","journal-title":"Med Clin North Am"},{"key":"e_1_2_1_3_2","first-page":"373","article-title":"The gut mucosal barrier in bone marrow transplantation","volume":"5","author":"Fegan C","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600750211"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)60121-8"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198411153112004"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)53755-8"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1200\/JCO.1985.3.8.1068","article-title":"Medical castration produced by GnRH analogue leuprolide to treat metastatic breast cancer","volume":"3","author":"Harvey HA","year":"1984","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.1.115"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)60486-7"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-1-95"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)59655-1"},{"key":"e_1_2_1_13_2","unstructured":"GhalieR RichmanCM FitszimmonsWE DolceAH MansonSD KaizerH:Prevention of menstrual bleeding with leuprolide in premenopausal females undergoing bone marrow transplantation. Proc ISEH abst 576 1990."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199018060-00004"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(89)90705-9"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(88)90009-0"},{"key":"e_1_2_1_17_2","first-page":"1295","article-title":"Control of hypermenorrhea in female patients with severe thrombocytopenia with a special relevance to the efficacy of LH\u2010RH analogue","volume":"24","author":"Yagita M","year":"1983","journal-title":"Jpn J Clin Hematol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198309000-00005"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)92301-1"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1004954"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.2830420404","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.2830420404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:53:09Z","timestamp":1695880389000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.2830420404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,4]]}},"alternative-id":["10.1002\/ajh.2830420404"],"URL":"https:\/\/doi.org\/10.1002\/ajh.2830420404","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,4]]}}}